JP2023520038A5 - - Google Patents
Info
- Publication number
- JP2023520038A5 JP2023520038A5 JP2022559858A JP2022559858A JP2023520038A5 JP 2023520038 A5 JP2023520038 A5 JP 2023520038A5 JP 2022559858 A JP2022559858 A JP 2022559858A JP 2022559858 A JP2022559858 A JP 2022559858A JP 2023520038 A5 JP2023520038 A5 JP 2023520038A5
- Authority
- JP
- Japan
- Prior art keywords
- acid sequence
- amino acid
- protein
- approximately
- immune response
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063003281P | 2020-03-31 | 2020-03-31 | |
| US63/003,281 | 2020-03-31 | ||
| US202063124397P | 2020-12-11 | 2020-12-11 | |
| US63/124,397 | 2020-12-11 | ||
| PCT/IB2021/052710 WO2021198963A1 (en) | 2020-03-31 | 2021-03-31 | Vectors for producing virus-like particles and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023520038A JP2023520038A (ja) | 2023-05-15 |
| JP2023520038A5 true JP2023520038A5 (https=) | 2024-04-10 |
Family
ID=77927692
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022559858A Pending JP2023520038A (ja) | 2020-03-31 | 2021-03-31 | ウイルス様粒子を作製するためのベクターおよびその使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230140025A1 (https=) |
| EP (1) | EP4127191A4 (https=) |
| JP (1) | JP2023520038A (https=) |
| KR (1) | KR20230034934A (https=) |
| CN (1) | CN115956125A (https=) |
| AU (1) | AU2021249531A1 (https=) |
| BR (1) | BR112022019647A2 (https=) |
| CA (1) | CA3176880A1 (https=) |
| MX (1) | MX2022011734A (https=) |
| WO (1) | WO2021198963A1 (https=) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2431963T3 (es) * | 2002-07-05 | 2013-11-28 | Folia Biotech Inc. | Partícula viral adyuvante |
| US9290778B2 (en) * | 2013-11-22 | 2016-03-22 | Mediphage Bioceuticals, Inc. | DNA vector production system |
| US9862954B2 (en) * | 2012-11-22 | 2018-01-09 | Mediphage Bioceuticals, Inc. | DNA vector production system |
| CA2906770A1 (en) * | 2013-03-15 | 2014-09-18 | Vlp Biotech, Inc. | Palivizumab epitope-based virus-like particles |
| EP3275462A1 (en) * | 2016-07-27 | 2018-01-31 | Fundació Privada Institut de Recerca de la SIDA-Caixa | Virus-like particles with high-density coating for the production of neutralizing antibodies |
| US10960070B2 (en) * | 2016-10-25 | 2021-03-30 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Prefusion coronavirus spike proteins and their use |
-
2021
- 2021-03-31 BR BR112022019647A patent/BR112022019647A2/pt unknown
- 2021-03-31 JP JP2022559858A patent/JP2023520038A/ja active Pending
- 2021-03-31 AU AU2021249531A patent/AU2021249531A1/en not_active Abandoned
- 2021-03-31 WO PCT/IB2021/052710 patent/WO2021198963A1/en not_active Ceased
- 2021-03-31 MX MX2022011734A patent/MX2022011734A/es unknown
- 2021-03-31 KR KR1020227038042A patent/KR20230034934A/ko active Pending
- 2021-03-31 CA CA3176880A patent/CA3176880A1/en active Pending
- 2021-03-31 CN CN202180038779.4A patent/CN115956125A/zh active Pending
- 2021-03-31 EP EP21779933.7A patent/EP4127191A4/en active Pending
-
2022
- 2022-09-30 US US17/937,234 patent/US20230140025A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111217919B (zh) | 一种基于火球菌铁蛋白的新型冠状病毒s蛋白双区域亚单位纳米疫苗 | |
| CN111560074B (zh) | 一种基于幽门螺旋杆菌铁蛋白的新型冠状病毒s蛋白单区域亚单位纳米疫苗 | |
| CN111607002B (zh) | 一种基于幽门螺旋杆菌铁蛋白的新型冠状病毒s蛋白双区域亚单位纳米疫苗 | |
| CN111217918A (zh) | 一种基于2,4-二氧四氢喋啶合酶的新型冠状病毒s蛋白双区域亚单位纳米疫苗 | |
| CN113943373B (zh) | 一种β冠状病毒多聚体抗原、其制备方法和应用 | |
| CN114127101A (zh) | 用于治疗或预防呼吸道感染的亚单位疫苗 | |
| WO2023186170A1 (zh) | 一种新冠病毒Delta和Omicron变异株嵌合抗原、其制备方法和应用 | |
| JP2008535800A5 (https=) | ||
| CN116041448B (zh) | 新型冠状病毒免疫原性物质、其制备方法和应用 | |
| JP2015509707A5 (https=) | ||
| CN114213548B (zh) | 同时诱导抗多种病毒的免疫应答的方法 | |
| CN112552413B (zh) | 新型冠状病毒重组蛋白亚单位疫苗 | |
| CN111978400A (zh) | 一种裂谷热病毒人源单克隆抗体及其应用 | |
| WO2023138334A1 (zh) | 一种重组新型冠状病毒蛋白疫苗、其制备方法和应用 | |
| WO2023051701A1 (zh) | 抗SARS-CoV-2感染的mRNA、蛋白以及抗SARS-CoV-2感染的疫苗 | |
| CN114634578A (zh) | 针对新型冠状病毒感染的疫苗组合物 | |
| CN118440190B (zh) | 一种人源化狂犬病病毒纳米抗体、重组纳米抗体蛋白及在制备狂犬病防治产品中的应用 | |
| CN118994328A (zh) | 呼吸道合胞病毒疫苗及其制备方法和应用 | |
| CN107344969A (zh) | 一种纳米流感疫苗及构建方法和应用 | |
| CN119735707B (zh) | 一种猴痘病毒多抗原单价疫苗及其应用 | |
| CN102464721B (zh) | 针对人肠道病毒71型的重组广谱性疫苗 | |
| JP2023520038A5 (https=) | ||
| CN115850395B (zh) | 一种流感病毒通用型纳米颗粒疫苗及其制备方法 | |
| CN114717205A (zh) | 一种冠状病毒RBDdm变异体及其应用 | |
| WO2022127820A1 (zh) | 病原样抗原疫苗及其制备方法 |